'Re­call ready': FDA urges com­pa­nies to com­ply with drug re­call guid­ance

The FDA has fi­nal­ized guid­ance to help com­pa­nies quick­ly re­call prod­ucts and take the nec­es­sary steps be­fore a prod­uct reach­es the re­call stage, as part …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.